Tower Research Capital (TRC)’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.6K | Sell |
|
|||||
|
2025
Q2 | $17.2K | Buy |
|
|||||
|
2025
Q1 | $8.38K | Buy |
|
|||||
|
2024
Q4 | $10.8K | Sell |
|
|||||
|
2024
Q3 | $10.9K | Sell |
|
|||||
|
2024
Q2 | $27.3K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $43.3K | Sell |
|
|||||
|
2023
Q3 | $50.2K | Buy |
|
|||||
|
2023
Q2 | $11.9K | Sell |
|
|||||
|
2023
Q1 | $95K | Buy |
|
|||||
|
2022
Q4 | $36K | Sell |
|
|||||
|
2022
Q3 | $470K | Buy |
|
|||||
|
2022
Q2 | $269K | Buy |
|
|||||
|
2022
Q1 | $164K | Buy |
|
|||||
|
2021
Q4 | $193K | Buy |
|
|||||
|
2021
Q3 | $130K | Buy |
|
|||||
|
2021
Q2 | $106K | Sell |
|
|||||
|
2021
Q1 | $266K | Buy |
|
|||||
|
2020
Q4 | $30K | Sell |
|
|||||
|
2020
Q3 | $81K | Sell |
|
|||||
|
2020
Q2 | $244K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $134K | Buy |
|
|||||
|
2019
Q3 | $52K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $118K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $25K | Sell |
|
|||||
|
2017
Q3 | $39K | Buy |
|
|||||
|
2017
Q2 | $6K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $2K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $8K | Sell |
|
|||||
|
2015
Q4 | $12K | Sell |
|
|||||
|
2015
Q3 | $14K | Buy |
|
|||||
|
2015
Q2 | $19K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $2K | Buy |
|